These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 34204265

  • 1. Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion.
    Park S, Nguyen MQ, Ta HKK, Nguyen MT, Lee G, Kim CJ, Jang YJ, Choe H.
    Int J Mol Sci; 2021 Jun 17; 22(12):. PubMed ID: 34204265
    [Abstract] [Full Text] [Related]

  • 2. Generation of Potent Anti-HER1/2 Immunotoxins by Protein Ligation Using Split Inteins.
    Pirzer T, Becher KS, Rieker M, Meckel T, Mootz HD, Kolmar H.
    ACS Chem Biol; 2018 Aug 17; 13(8):2058-2066. PubMed ID: 29920062
    [Abstract] [Full Text] [Related]

  • 3. Modular Conjugation of a Potent Anti-HER2 Immunotoxin Using Coassociating Peptides.
    Stoessel A, Groysbeck N, Guyot L, Barret L, Nominé Y, Nguekeu-Zebaze L, Bender A, Voilquin L, Lutz T, Pallaoro N, Blocat M, Deville C, Masson M, Zuber G, Chatton B, Donzeau M.
    Bioconjug Chem; 2020 Oct 21; 31(10):2421-2430. PubMed ID: 32996763
    [Abstract] [Full Text] [Related]

  • 4. Novel Anti-Mesothelin Nanobodies and Recombinant Immunotoxins with Pseudomonas Exotoxin Catalytic Domain for Cancer Therapeutics.
    Nguyen MQ, Kim DH, Shim HJ, Ta HKK, Vu TL, Nguyen TKO, Lim JC, Choe H.
    Mol Cells; 2023 Dec 31; 46(12):764-777. PubMed ID: 38052492
    [Abstract] [Full Text] [Related]

  • 5. Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.
    Della Cristina P, Castagna M, Lombardi A, Barison E, Tagliabue G, Ceriotti A, Koutris I, Di Leandro L, Giansanti F, Vago R, Ippoliti R, Flavell SU, Flavell DJ, Colombatti M, Fabbrini MS.
    Microb Cell Fact; 2015 Feb 13; 14():19. PubMed ID: 25889802
    [Abstract] [Full Text] [Related]

  • 6. Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors.
    Zielinski R, Lyakhov I, Jacobs A, Chertov O, Kramer-Marek G, Francella N, Stephen A, Fisher R, Blumenthal R, Capala J.
    J Immunother; 2009 Oct 13; 32(8):817-25. PubMed ID: 19752752
    [Abstract] [Full Text] [Related]

  • 7. Novel recombinant anti-HER2/neu immunotoxin: design and antitumor efficiency.
    Sokolova EA, Zdobnova TA, Stremovskiy OA, Balalaeva IV, Deyev SM.
    Biochemistry (Mosc); 2014 Dec 13; 79(12):1376-81. PubMed ID: 25716732
    [Abstract] [Full Text] [Related]

  • 8. Design and construction of scFv-PE35KDEL as a novel immunotoxin against human epidermal growth factor receptor 2 for cancer therapy.
    Shariaty Vaziri Z, Shafiee F, Akbari V.
    Biotechnol Lett; 2023 Apr 13; 45(4):537-550. PubMed ID: 36807722
    [Abstract] [Full Text] [Related]

  • 9. Expression and purification of recombinant immunotoxin--a fusion protein stabilizes a single-chain Fv (scFv) in denaturing condition.
    Kim SH.
    Protein Expr Purif; 2003 Jan 13; 27(1):85-9. PubMed ID: 12509988
    [Abstract] [Full Text] [Related]

  • 10. A chemical conjugate between HER2-targeting antibody fragment and Pseudomonas exotoxin A fragment demonstrates cytotoxic effects on HER2-expressing breast cancer cells.
    Lee S, Park S, Nguyen MT, Lee E, Kim J, Baek S, Kim CJ, Jang YJ, Choe H.
    BMB Rep; 2019 Aug 13; 52(8):496-501. PubMed ID: 30670149
    [Abstract] [Full Text] [Related]

  • 11. [Soluble expression of recombinant immunotoxin against human bladder carcinoma and its anti-tumor activity].
    Chao K, He D, Yang H, Zhang Z, Lin Q, Guo AG, Huang HL.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep 13; 20(5):568-71. PubMed ID: 15367349
    [Abstract] [Full Text] [Related]

  • 12. Breast cancer targeted/ therapeutic with double and triple fusion Immunotoxins.
    Goleij Z, Mahmoodzadeh Hosseini H, Sedighian H, Behzadi E, Halabian R, Sorouri R, Imani Fooladi AA.
    J Steroid Biochem Mol Biol; 2020 Jun 13; 200():105651. PubMed ID: 32147458
    [Abstract] [Full Text] [Related]

  • 13. [Studies of the expression, purification, renaturation and biologic activity of an anti-CEA immunotoxin].
    Yang H, He D, Chao K, Lin Q, You S, Huang HL.
    Sheng Wu Gong Cheng Xue Bao; 2004 May 13; 20(3):348-51. PubMed ID: 15971603
    [Abstract] [Full Text] [Related]

  • 14. Construction and in vitro evaluation of RFT5(scFv)-ETA', a new recombinant single-chain immunotoxin with specific cytotoxicity toward CD25+ Hodgkin-derived cell lines.
    Barth S, Huhn M, Wels W, Diehl V, Engert A.
    Int J Mol Med; 1998 Jan 13; 1(1):249-56. PubMed ID: 9852227
    [Abstract] [Full Text] [Related]

  • 15. Expression, purification, and characterization of an immunotoxin containing a humanized anti-CD25 single-chain fragment variable antibody fused to a modified truncated Pseudomonas exotoxin A.
    Wang H, Dai J, Li B, Fan K, Peng L, Zhang D, Cao Z, Qian W, Wang H, Zhao J, Guo Y.
    Protein Expr Purif; 2008 Mar 13; 58(1):140-7. PubMed ID: 17950620
    [Abstract] [Full Text] [Related]

  • 16. Expression of VGRNb-PE immunotoxin in transplastomic lettuce (Lactuca sativa L.).
    Mirzaee M, Jalali-Javaran M, Moieni A, Zeinali S, Behdani M.
    Plant Mol Biol; 2018 May 13; 97(1-2):103-112. PubMed ID: 29633168
    [Abstract] [Full Text] [Related]

  • 17. Molecular construction and characterization of a novel exotoxin fusion protein that selectively blocks the B7:CD28 costimulatory signal system.
    Xi Y, Yuan Z, Zhang H, Guan H, Kong F, Liu N, Liang F, Cui J, Guo S, Sun Y, Xi C.
    J Immunother; 2006 May 13; 29(6):586-95. PubMed ID: 17063121
    [Abstract] [Full Text] [Related]

  • 18. Target-specific cytotoxic effects on HER2-expressing cells by the tripartite fusion toxin ZHER2:2891-ABD-PE38X8, including a targeting affibody molecule and a half-life extension domain.
    Liu H, Seijsing J, Frejd FY, Tolmachev V, Gräslund T.
    Int J Oncol; 2015 Aug 13; 47(2):601-9. PubMed ID: 26046132
    [Abstract] [Full Text] [Related]

  • 19. Recombinant immunotoxins containing the VH or VL domain of monoclonal antibody B3 fused to Pseudomonas exotoxin.
    Brinkmann U, Lee BK, Pastan I.
    J Immunol; 1993 Apr 01; 150(7):2774-82. PubMed ID: 8454854
    [Abstract] [Full Text] [Related]

  • 20. An anti-GD2 single chain Fv selected by phage display and fused to Pseudomonas exotoxin A develops specific cytotoxic activity against neuroblastoma derived cell lines.
    Tur MK, Sasse S, Stöcker M, Djabelkhir K, Huhn M, Matthey B, Gottstein C, Pfitzner T, Engert A, Barth S.
    Int J Mol Med; 2001 Nov 01; 8(5):579-84. PubMed ID: 11605031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.